PH17114A - Novel(piperidinylalkyl)quinazoline derivatives - Google Patents

Novel(piperidinylalkyl)quinazoline derivatives

Info

Publication number: PH17114A
Authority: PH; Philippines
Prior art keywords: alkyl; group; aryl; independently selected; substituents
Prior art date: 1979-01-08

Application number

PH23489A

Other languages

English (en)

Inventor

Vandenber Jan

Ludo E J Kennis

Marcel J M C Van Der Aa

Albert H M Th Van Heertum

Original Assignee

Janssen Pharmaceutica Nv

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1979-01-08

Filing date

1980-01-08

Publication date

1984-06-01

Family has litigation

First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=26669096&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=PH17114(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.

1980-01-08 Application filed by Janssen Pharmaceutica Nv filed Critical Janssen Pharmaceutica Nv

1984-06-01 Publication of PH17114A publication Critical patent/PH17114A/en

Links

125000002294 quinazolinyl group Chemical class N1=C(N=CC2=CC=CC=C12)* 0.000 title abstract 2
125000000217 alkyl group Chemical group 0.000 abstract 7
125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 abstract 4
125000003545 alkoxy group Chemical group 0.000 abstract 3
125000003118 aryl group Chemical group 0.000 abstract 3
125000001424 substituent group Chemical group 0.000 abstract 3
125000002023 trifluoromethyl group Chemical group FC(F)(F)* 0.000 abstract 3
125000002947 alkylene group Chemical group 0.000 abstract 2
125000001475 halogen functional group Chemical group 0.000 abstract 2
229910052739 hydrogen Inorganic materials 0.000 abstract 2
239000001257 hydrogen Substances 0.000 abstract 2
125000002924 primary amino group Chemical group [H]N([H])* 0.000 abstract 2
QZAYGJVTTNCVMB-UHFFFAOYSA-N serotonin Chemical compound C1=C(O)C=C2C(CCN)=CNC2=C1 QZAYGJVTTNCVMB-UHFFFAOYSA-N 0.000 abstract 2
UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 abstract 1
125000004432 carbon atom Chemical group C* 0.000 abstract 1
125000002915 carbonyl group Chemical group [*:2]C([*:1])=O 0.000 abstract 1
150000001875 compounds Chemical class 0.000 abstract 1
125000004093 cyano group Chemical group *C#N 0.000 abstract 1
229910052736 halogen Inorganic materials 0.000 abstract 1
150000002367 halogens Chemical class 0.000 abstract 1
150000002431 hydrogen Chemical class 0.000 abstract 1
125000004356 hydroxy functional group Chemical group O* 0.000 abstract 1
125000000449 nitro group Chemical group [O-][N+](*)=O 0.000 abstract 1
125000004076 pyridyl group Chemical group 0.000 abstract 1
229920006395 saturated elastomer Polymers 0.000 abstract 1
229940076279 serotonin Drugs 0.000 abstract 1
125000001544 thienyl group Chemical group 0.000 abstract 1
125000002813 thiocarbonyl group Chemical group *C(*)=S 0.000 abstract 1

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D211/08—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms
- C07D211/18—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms
- C07D211/30—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by doubly bound oxygen or sulfur atoms or by two oxygen or sulfur atoms singly bound to the same carbon atom
- C07D211/32—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by doubly bound oxygen or sulfur atoms or by two oxygen or sulfur atoms singly bound to the same carbon atom by oxygen atoms
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/08—Vasodilators for multiple indications
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/70—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings condensed with carbocyclic rings or ring systems
- C07D239/72—Quinazolines; Hydrogenated quinazolines
- C07D239/78—Quinazolines; Hydrogenated quinazolines with hetero atoms directly attached in position 2
- C07D239/80—Oxygen atoms
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/70—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings condensed with carbocyclic rings or ring systems
- C07D239/72—Quinazolines; Hydrogenated quinazolines
- C07D239/86—Quinazolines; Hydrogenated quinazolines with hetero atoms directly attached in position 4
- C07D239/88—Oxygen atoms
- C07D239/90—Oxygen atoms with acyclic radicals attached in position 2 or 3
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/70—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings condensed with carbocyclic rings or ring systems
- C07D239/72—Quinazolines; Hydrogenated quinazolines
- C07D239/95—Quinazolines; Hydrogenated quinazolines with hetero atoms directly attached in positions 2 and 4
- C07D239/96—Two oxygen atoms

Landscapes

Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
General Health & Medical Sciences (AREA)
Veterinary Medicine (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Bioinformatics & Cheminformatics (AREA)
Pharmacology & Pharmacy (AREA)
Engineering & Computer Science (AREA)
Animal Behavior & Ethology (AREA)
Public Health (AREA)
Heart & Thoracic Surgery (AREA)
Cardiology (AREA)
Biomedical Technology (AREA)
Neurology (AREA)
Neurosurgery (AREA)
Plural Heterocyclic Compounds (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Hydrogenated Pyridines (AREA)

PH23489A 1979-01-08 1980-01-08 Novel(piperidinylalkyl)quinazoline derivatives PH17114A (en)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
US149379A	1979-01-08	1979-01-08
US06/084,272 US4335127A (en)	1979-01-08	1979-10-12	Piperidinylalkyl quinazoline compounds, composition and method of use

Publications (1)

Publication Number	Publication Date
PH17114A true PH17114A (en)	1984-06-01

Family

ID=26669096

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
PH23489A PH17114A (en)	1979-01-08	1980-01-08	Novel(piperidinylalkyl)quinazoline derivatives

Country Status (32)

Country	Link
US (1)	US4335127A (da)
EP (1)	EP0013612B1 (da)
JP (1)	JPS55105679A (da)
KR (3)	KR850000684B1 (da)
AT (1)	ATE5258T1 (da)
AU (1)	AU536175B2 (da)
CA (1)	CA1132557A (da)
CS (1)	CS223977B2 (da)
CY (1)	CY1252A (da)
DE (1)	DE3065489D1 (da)
DK (1)	DK170669B1 (da)
ES (1)	ES8101586A1 (da)
FI (1)	FI66609C (da)
GR (1)	GR67304B (da)
HK (1)	HK76284A (da)
HU (1)	HU184222B (da)
IE (1)	IE49351B1 (da)
IL (1)	IL59084A (da)
LU (1)	LU88219I2 (da)
MA (1)	MA18694A1 (da)
MY (1)	MY8700555A (da)
NL (1)	NL930018I2 (da)
NO (1)	NO155243C (da)
NZ (1)	NZ192551A (da)
PH (1)	PH17114A (da)
PL (1)	PL125789B1 (da)
PT (1)	PT70662A (da)
RO (1)	RO79148A (da)
SG (1)	SG48684G (da)
SU (1)	SU1041034A3 (da)
YU (1)	YU42957B (da)
ZA (1)	ZA8082B (da)

Families Citing this family (111)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
ZA806501B (en) *	1979-10-27	1981-10-28	Richardson Merrell Inc	4-(4-alkyl-aroyl-1-piperidino)butyrophenone antipsychotic agents
CA1183847A (en) *	1981-10-01	1985-03-12	Georges Van Daele	N-(3-hydroxy-4-piperidinyl)benzamide derivatives
US4355037A (en) *	1981-11-12	1982-10-19	Hoechst-Roussel Pharmaceuticals	3-(4-Piperidyl)-1,2-benzisoxales
DK159420C (da) *	1983-03-09	1991-03-11	Ciba Geigy Ag	N-(piperidinyl-alkyl)-carboxamider og salte deraf, farmaceutiske praeparater indeholdende disse forbindelser samt anvendelsen af forbindelserne til fremstilling af antipsykotiske farmaceutiske praeparater
ZA841728B (en) *	1983-03-09	1984-11-28	Ciba Geigy Ag	Novel carboxamides
JPS608274A (ja) *	1983-06-27	1985-01-17	Fujisawa Pharmaceut Co Ltd	新規キナゾリノン誘導体およびその製造法・並びに抗アレルギ−剤
PH23995A (en) *	1984-01-09	1990-02-09	Janssen Pharmaceutica Nv	4((bicycle heterocyclyl)-methyl and hetero)piperidines
CS247557B1 (en) *	1984-04-06	1987-01-15	Ludmila Fisnerova	Esters of 3-(2-hydroxyethyl)-4(3h)-quinazolinone
EP0177078A1 (en) *	1984-09-12	1986-04-09	Duphar International Research B.V	Spasmolytically active tertiary amine derivatives and method of preparing the same
US4634769A (en) *	1984-09-25	1987-01-06	Ortho Pharmaceutical Corporation	Process for the preparation of 8-halo-5,6-dialkoxyquinazoline-2,4-diones and their salts
CA1246074A (en) *	1984-12-05	1988-12-06	Albertus H.M.T. Van Heertum	Derivatives of hydroxy- or amino-substituted (piperidinylalkyl)quinazolines
US4665075A (en) *	1984-12-05	1987-05-12	Janssen Pharmaceutica N.V.	Derivatives of hydroxy- or amino-substituted (piperidinylalkyl)quinazolines
US4804663A (en) *	1985-03-27	1989-02-14	Janssen Pharmaceutica N.V.	3-piperidinyl-substituted 1,2-benzisoxazoles and 1,2-benzisothiazoles
JPH0615529B2 (ja) *	1985-04-01	1994-03-02	エーザイ株式会社	新規ピペリジン誘導体
FR2581993B1 (fr) *	1985-05-14	1988-03-18	Synthelabo	Derives de (benzoyl-4 piperidino)-2 phenyl-1 alcanols, leur preparation et leur application en therapeutique
US4753944A (en) *	1985-11-04	1988-06-28	American Cyanamid Company	Pharmaceutical methods of using 3-heteroarylalkyl-4-quinazolinones
US4710502A (en) *	1985-11-04	1987-12-01	American Cyanamid Company	3-heteroarylalkyl-4-quinazolinones
DK623586A (da) *	1985-12-27	1987-06-28	Eisai Co Ltd	Piperidinderivater eller salte deraf og farmaceutiske kompositioner indeholdende forbindelserne
US4874766A (en) *	1986-09-22	1989-10-17	Janssen Pharmaceutica N.V.	Method of promoting wound-healing
ES2094718T3 (es) *	1986-09-22	1997-02-01	Janssen Pharmaceutica Nv	Antagonistas de la serotonine para el tratamiento de heridas.
JP2660407B2 (ja) *	1986-09-26	1997-10-08	住友製薬株式会社	新規なイミド誘導体
DE3738844A1 (de) *	1987-11-16	1989-05-24	Merck Patent Gmbh	Analgetikum
ATE137964T1 (de) *	1988-03-28	1996-06-15	Janssen Pharmaceutica Nv	Mittel zur konservierung oder wiederherstellung der gesunden haut
IL90879A0 (en) *	1988-09-02	1990-02-09	Janssen Pharmaceutica Nv	3-piperidinyl-indazole derivatives,their preparation and antihypertensive compositions containing them
CA1340821C (en) *	1988-10-06	1999-11-16	Nobuyuki Fukazawa	Heterocyclic compounds and anticancer-drug reinforcing agents containing them as effective components
FR2644786B1 (fr) *	1989-03-21	1993-12-31	Adir Cie	Nouveaux derives fluoro-4 benzoiques, leurs procedes de preparation et les compositions pharmaceutiques qui les contiennent
JP2744634B2 (ja) *	1989-04-14	1998-04-28	三菱重工業株式会社	ゴミ焼却装置
US5561128A (en) *	1989-05-19	1996-10-01	Hoechst-Roussel Pharmaceuticals, Inc.	N-[(4-(heteroaryl)-1-piperidinyl)alkyl]-10,11-dihydro-5H-dibenz[B,F]azepines and related compounds and their therapeutic utility
US5776963A (en) *	1989-05-19	1998-07-07	Hoechst Marion Roussel, Inc.	3-(heteroaryl)-1- (2,3-dihydro-1h-isoindol-2-yl)alkyl!pyrrolidines and 3-(heteroaryl)-1- (2,3-dihydro-1h-indol-1-yl)alkyl!pyrrolidines and related compounds and their therapeutic untility
US5364866A (en)	1989-05-19	1994-11-15	Hoechst-Roussel Pharmaceuticals, Inc.	Heteroarylpiperidines, pyrrolidines and piperazines and their use as antipsychotics and analetics
IE913473A1 (en) *	1990-10-15	1992-04-22	Fujisawa Pharmaceutical Co	Quinazoline derivatives and their preparation
US5158953A (en) *	1991-08-13	1992-10-27	National Science Council	2-substituted methyl-2,3-dihydroimidazo[1,2-c]quinazolin-5(6H)-ones (thiones), the preparation and use thereof
DE4138756A1 (de) *	1991-11-26	1993-05-27	Troponwerke Gmbh & Co Kg	Kombination mit neuroprotektiver wirkung
US5266571A (en) *	1992-01-09	1993-11-30	Amer Moh Samir	Treatment of hemorrhoids with 5-HT2 antagonists
GB9202915D0 (en) *	1992-02-12	1992-03-25	Wellcome Found	Chemical compounds
CA2129995C (en) *	1992-02-13	2000-04-11	Albert A. Carr	Piperidinyl thiacyclic derivatives
FR2696744B1 (fr) *	1992-10-12	1994-12-30	Logeais Labor Jacques	Dérivés de 2-pyrrolidone, leur procédé de préparation et leurs applications en thérapeutique.
EP0626373B1 (en) *	1993-05-26	1998-12-23	Sumitomo Pharmaceuticals Company, Limited	Quinazolinone derivatives
CN1074923C (zh) *	1993-11-19	2001-11-21	詹森药业有限公司	微囊密封的3-哌啶基取代的1,2-苯并异唑类和1,2-苯并异噻唑类
EP0661266A1 (en) *	1993-12-27	1995-07-05	Toa Eiyo Ltd.	Substituted cyclic amine compounds as 5HT2 antagonists
US6184377B1 (en)	1997-12-15	2001-02-06	Sepracor Inc.	Compositions containing N-amino- and N-hydroxy-quinazolinones and methods for preparing libraries thereof
ES2244243T3 (es) *	1998-10-16	2005-12-01	Sumitomo Pharmaceuticals Company, Limited	Deerivados de quinazolinona.
GB9903784D0 (en) *	1999-02-18	1999-04-14	Lilly Co Eli	Pharmaceutical compounds
KR20010108394A (ko)	1999-03-26	2001-12-07	다비드 에 질레스	신규 화합물
US6476041B1 (en) *	1999-10-29	2002-11-05	Merck & Co., Inc.	1,4 substituted piperidinyl NMDA/NR2B antagonists
US6844338B2 (en)	2000-05-18	2005-01-18	Eli Lilly And Company	Piperidyindoles as serotonin receptor ligands
GB2362381A (en) *	2000-05-18	2001-11-21	Lilly Co Eli	Pharmaceutically active indolyl-piperidines
GB0013060D0 (en) *	2000-05-31	2000-07-19	Astrazeneca Ab	Chemical compounds
GB0021670D0 (en) *	2000-09-04	2000-10-18	Astrazeneca Ab	Chemical compounds
DE10101324C1 (de) *	2001-01-13	2001-12-13	Ibfb Gmbh Privates Inst Fuer B	1-Dimercaptoalkylchinazolin-2,4-(1H,3H)-dione als Matrix-Metalloproteinase(MMP)-Inhibitoren
GB0117899D0 (en) *	2001-07-23	2001-09-12	Astrazeneca Ab	Chemical compounds
SE0102809D0 (sv) *	2001-08-22	2001-08-22	Astrazeneca Ab	Novel compounds
GB0126433D0 (en) *	2001-11-03	2002-01-02	Astrazeneca Ab	Compounds
TW200813014A (en) *	2002-03-28	2008-03-16	Astrazeneca Ab	Quinazoline derivatives
US6924285B2 (en) *	2002-03-30	2005-08-02	Boehringer Ingelheim Pharma Gmbh & Co.	Bicyclic heterocyclic compounds, pharmaceutical compositions containing these compounds, their use and process for preparing them
EP1560814A1 (en) *	2002-11-13	2005-08-10	Synthon B.V.	Process for making risperidone and intermediates therefor
EP1615923A1 (en) *	2003-04-22	2006-01-18	Synthon B.V.	Risperidone monohydrochloride
GB0309009D0 (en) *	2003-04-22	2003-05-28	Astrazeneca Ab	Quinazoline derivatives
GB0309850D0 (en) *	2003-04-30	2003-06-04	Astrazeneca Ab	Quinazoline derivatives
AU2004272345A1 (en) *	2003-09-16	2005-03-24	Astrazeneca Ab	Quinazoline derivatives
GB0321648D0 (en) *	2003-09-16	2003-10-15	Astrazeneca Ab	Quinazoline derivatives
EP1664028A1 (en) *	2003-09-16	2006-06-07	AstraZeneca AB	Quinazoline derivatives as tyrosine kinase inhibitors
MXPA06002964A (es) *	2003-09-16	2006-06-14	Astrazeneca Ab	Derivados de quinazolina como inhibidores de cinasa de tirosina.
US8318752B2 (en) *	2003-09-19	2012-11-27	Astrazeneca Ab	4-(3-chloro-2-fluoroanilino)-7-methoxy-6-{[1-(N-methylcarbamoyl-methyl)piperidin-4-yl]oxy}quinazoline, its pharmaceutically acceptable salts, and pharmaceutical compositions comprising the same
ATE353888T1 (de) *	2003-09-19	2007-03-15	Astrazeneca Ab	Chinazolinderivate
EP1670786A1 (en) *	2003-09-25	2006-06-21	Astrazeneca AB	Quinazoline derivatives
GB0322409D0 (en) *	2003-09-25	2003-10-29	Astrazeneca Ab	Quinazoline derivatives
SG131946A1 (en) *	2003-10-24	2007-05-28	Hoffmann La Roche	Ccr3 receptor antagonists
GB0326459D0 (en) *	2003-11-13	2003-12-17	Astrazeneca Ab	Quinazoline derivatives
ES2551027T3 (es) *	2003-11-20	2015-11-13	Janssen Pharmaceutica Nv	2-Quinolinonas 7-fenilalquil sustituidas y 2-quinoxalinonas como inhibidores de poli(ADP-ribosa) polimerasa
EA009875B1 (ru)	2003-11-20	2008-04-28	Янссен Фармацевтика Н.В.	6-алкенил и 6-фенилалкил замещенные 2-хинолиноны и 2-хиноксалиноны в качестве ингибиторов поли(адф-рибоза) полимеразы
SG151249A1 (en) *	2003-12-05	2009-04-30	Janssen Pharmaceutica Nv	6-substituted 2-quinolinones and 2-quinoxalinones as poly(adp-ribose) polymerase inhibitors
DE602005010824D1 (de) *	2004-02-03	2008-12-18	Astrazeneca Ab	Chinazolinderivate
WO2005118572A1 (en) *	2004-06-04	2005-12-15	Astrazeneca Ab	Quinazoline derivatives as erbb receptor tyrosine kinases
KR101286969B1 (ko)	2004-06-30	2013-07-23	얀센 파마슈티카 엔.브이.	Ｐａｒｐ 저해제로서의 퀴나졸리논 유도체
CN1980913B (zh)	2004-06-30	2011-12-14	詹森药业有限公司	作为parp抑制剂的喹唑啉二酮衍生物
ES2563954T3 (es) *	2004-06-30	2016-03-16	Janssen Pharmaceutica Nv	Derivados de ftalazina como inhibidores de PARP
WO2006064196A1 (en)	2004-12-14	2006-06-22	Astrazeneca Ab	Pyrazolopyrimidine compounds as antitumor agents
ATE521603T1 (de) *	2005-02-26	2011-09-15	Astrazeneca Ab	Chinazolinderivate als tyrosinkinaseinhibitoren
GB0504474D0 (en) *	2005-03-04	2005-04-13	Astrazeneca Ab	Chemical compounds
GB0508715D0 (en) *	2005-04-29	2005-06-08	Astrazeneca Ab	Chemical compounds
GB0508717D0 (en) *	2005-04-29	2005-06-08	Astrazeneca Ab	Chemical compounds
US7820683B2 (en) *	2005-09-20	2010-10-26	Astrazeneca Ab	4-(1H-indazol-5-yl-amino)-quinazoline compounds as erbB receptor tyrosine kinase inhibitors for the treatment of cancer
JP2009508917A (ja) *	2005-09-20	2009-03-05	アストラゼネカアクチボラグ	抗癌剤としてのキナゾリン誘導体
ATE443053T1 (de) *	2005-12-02	2009-10-15	Astrazeneca Ab	Als inhibitoren von erbb-tyrosinkinase verwendete chinazoleinderivate
EP1957499A1 (en) *	2005-12-02	2008-08-20	AstraZeneca AB	4-anilino-substituted quinazoline derivatives as tyrosine kinase inhibitors
EP1921070A1 (de) *	2006-11-10	2008-05-14	Boehringer Ingelheim Pharma GmbH & Co. KG	Bicyclische Heterocyclen, diese Verbindungen enthaltende Arzneimittel, deren Verwendung und Verfahren zu ihrer Herstelllung
EA200901041A1 (ru) *	2007-02-06	2010-02-26	Бёрингер Ингельхайм Интернациональ Гмбх	Бициклические гетероциклы, содержащие эти соединения лекарственные средства, их применение и способ их получения
SI2134691T1 (sl) *	2007-03-08	2012-06-29	Janssen Pharmaceutica Nv	Derivati kvinolina kot PARP in TANK inhibitorji
PL2215075T3 (pl) *	2007-10-26	2014-04-30	Janssen Pharmaceutica Nv	Pochodne chinolinonu jako inhibitory PARP
JP5336516B2 (ja) *	2008-02-07	2013-11-06	ベーリンガーインゲルハイムインターナショナルゲゼルシャフトミットベシュレンクテルハフツング	スピロ環式複素環化合物、該化合物を含む医薬品、その使用及びその製造方法
RU2490260C2 (ru)	2008-03-27	2013-08-20	Янссен Фармацевтика Нв	Тетрагидрофенантридиноны и тетрагидроциклопентахинолиноны в качестве ингибиторов parp и ингибиторов полимеризации тубулина
AU2009228945B2 (en) *	2008-03-27	2013-05-02	Janssen Pharmaceutica Nv	Quinazolinone derivatives as tubulin polymerization inhibitors
BRPI0912170A2 (pt)	2008-05-13	2015-10-13	Astrazeneca Ab	composto, forma a, processo para a preparação da mesma, composição farmacêutica, uso de um composto, e, método para tratar um câncer em um animal de sangue quente
CA2733153C (en) *	2008-08-08	2016-11-08	Boehringer Ingelheim International Gmbh	Cyclohexyloxy substituted heterocycles, pharmaceutical compositions containing these compounds and processes for preparing them
US8440693B2 (en)	2009-12-22	2013-05-14	Novartis Ag	Substituted isoquinolinones and quinazolinones
CU24130B1 (es)	2009-12-22	2015-09-29	Novartis Ag	Isoquinolinonas y quinazolinonas sustituidas
BRPI1003506B1 (pt)	2010-09-24	2019-12-03	Ache Int Bvi Ltd	composto alquil-piperazino-fenil-4(3h)quinazolinonas e uso do composto alquil-piperazino-fenil-4(3h)quinazolinonas associado aos receptores serotoninérgicos 5-ht1a e 5-ht2a
CN104321325B (zh)	2012-05-24	2016-11-16	诺华股份有限公司	吡咯并吡咯烷酮化合物
WO2014115080A1 (en)	2013-01-22	2014-07-31	Novartis Ag	Pyrazolo[3,4-d]pyrimidinone compounds as inhibitors of the p53/mdm2 interaction
WO2014115077A1 (en)	2013-01-22	2014-07-31	Novartis Ag	Substituted purinone compounds
CN105209467B (zh)	2013-05-27	2018-06-08	诺华股份有限公司	咪唑并吡咯烷酮衍生物及其在治疗疾病中的用途
ES2656471T3 (es)	2013-05-28	2018-02-27	Novartis Ag	Derivados de pirazolo-pirrolidin-4-ona como inhibidores de BET y su uso en el tratamiento de enfermedades
ES2650562T3 (es)	2013-05-28	2018-01-19	Novartis Ag	Derivados de pirazolo-pirrolidin-4-ona y su uso en el tratamiento de enfermedades
US9550796B2 (en)	2013-11-21	2017-01-24	Novartis Ag	Pyrrolopyrrolone derivatives and their use as BET inhibitors
US9902703B2 (en)	2015-07-01	2018-02-27	Crinetics Pharmaceuticals, Inc.	Somatostatin modulators and uses thereof
CN106866625B (zh) *	2017-01-17	2019-12-13	上海鼎雅药物化学科技有限公司	酮色林的制备方法
WO2019023278A1 (en)	2017-07-25	2019-01-31	Crinetics Pharmaceuticals, Inc.	MODULATORS OF SOMATOSTATIN AND USES THEREOF
CN109157507A (zh) *	2018-09-14	2019-01-08	上海禾丰制药有限公司	酒石酸酮色林注射液及其制备方法
CN112142760A (zh) *	2020-10-20	2020-12-29	江苏法安德医药科技有限公司	一种酮色林中间体以及酮色林的制备方法
WO2023133524A1 (en) *	2022-01-06	2023-07-13	Terran Biosciences, Inc.	A process for synthesizing ketanserin

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US3322766A (en) *	1964-11-13	1967-05-30	Shulton Inc	3-beta-(4-pyridyl) ethyl-2, 3-dihydro-4(1h)-quinazolinones
US3635976A (en) *	1967-12-20	1972-01-18	Pennwalt Corp	1 - heterocyclic alkyl-1 2 3 4-tetrahydroquinazolinones and analgesic intermediates thereof
US4096144A (en) *	1970-12-08	1978-06-20	Sumitomo Chemical Company, Limited	Process for preparing quinazolinone derivatives and their 2-(N-mono-substituted amino)-phenyl ketone intermediate derivatives
US4099002A (en) *	1970-12-23	1978-07-04	Sumitomo Chemical Company, Limited	Quinazolinone derivatives and a process for production thereof
US4146717A (en) *	1972-04-07	1979-03-27	Sumitomo Chemical Company, Limited	Nitroquinazolinone compounds having antiviral properties
US4035369A (en) *	1975-10-08	1977-07-12	Janssen Pharmaceutica N.V.	1-Benzazolylalkyl-4-substituted-piperidines

1979
- 1979-10-12 US US06/084,272 patent/US4335127A/en not_active Expired - Lifetime
- 1979-12-21 GR GR60828A patent/GR67304B/el unknown
1980
- 1980-01-04 MA MA18891A patent/MA18694A1/fr unknown
- 1980-01-07 PL PL1980221249A patent/PL125789B1/pl unknown
- 1980-01-07 PT PT70662A patent/PT70662A/pt unknown
- 1980-01-07 CY CY1252A patent/CY1252A/xx unknown
- 1980-01-07 CS CS80157A patent/CS223977B2/cs unknown
- 1980-01-07 NZ NZ192551A patent/NZ192551A/en unknown
- 1980-01-07 IL IL59084A patent/IL59084A/xx unknown
- 1980-01-07 JP JP18680A patent/JPS55105679A/ja active Granted
- 1980-01-07 SU SU802863403A patent/SU1041034A3/ru active
- 1980-01-07 DE DE8080300059T patent/DE3065489D1/de not_active Expired
- 1980-01-07 FI FI800047A patent/FI66609C/fi not_active IP Right Cessation
- 1980-01-07 AU AU54381/80A patent/AU536175B2/en not_active Expired
- 1980-01-07 EP EP80300059A patent/EP0013612B1/en not_active Expired
- 1980-01-07 HU HU8025A patent/HU184222B/hu unknown
- 1980-01-07 NO NO800034A patent/NO155243C/no unknown
- 1980-01-07 CA CA343,181A patent/CA1132557A/en not_active Expired
- 1980-01-07 DK DK007280A patent/DK170669B1/da not_active IP Right Cessation
- 1980-01-07 LU LU88219C patent/LU88219I2/xx unknown
- 1980-01-07 AT AT80300059T patent/ATE5258T1/de not_active IP Right Cessation
- 1980-01-07 ZA ZA00800082A patent/ZA8082B/xx unknown
- 1980-01-07 IE IE21/80A patent/IE49351B1/en not_active IP Right Cessation
- 1980-01-08 PH PH23489A patent/PH17114A/en unknown
- 1980-01-08 YU YU46/80A patent/YU42957B/xx unknown
- 1980-01-08 ES ES487537A patent/ES8101586A1/es not_active Expired
- 1980-01-21 KR KR1019800000201A patent/KR850000684B1/ko not_active Expired
- 1980-02-20 RO RO80100248A patent/RO79148A/ro unknown
1984
- 1984-07-06 SG SG486/84A patent/SG48684G/en unknown
- 1984-08-02 KR KR1019840004608A patent/KR850000677B1/ko not_active Expired
- 1984-10-11 HK HK762/84A patent/HK76284A/en not_active IP Right Cessation
- 1984-12-20 KR KR1019840008162A patent/KR850000683B1/ko not_active Expired
1987
- 1987-12-30 MY MY555/87A patent/MY8700555A/xx unknown
1993
- 1993-03-02 NL NL930018C patent/NL930018I2/nl unknown

Also Published As

Publication number	Publication date
LU88219I2 (da)	1994-02-03
KR850002015A (ko)	1985-04-10
NL930018I1 (nl)	1993-05-03
HK76284A (en)	1984-10-19
YU4680A (en)	1983-06-30
NO800034L (no)	1980-07-09
NO155243C (no)	1987-03-04
DE3065489D1 (en)	1983-12-15
NL930018I2 (nl)	1993-09-16
CS223977B2 (en)	1983-11-25
IL59084A (en)	1984-02-29
NO155243B (no)	1986-11-24
IL59084A0 (en)	1980-05-30
CA1132557A (en)	1982-09-28
AU536175B2 (en)	1984-04-19
FI800047A7 (fi)	1980-07-09
NZ192551A (en)	1984-07-06
PT70662A (en)	1980-02-01
ES487537A0 (es)	1980-12-16
CY1252A (en)	1984-08-31
MY8700555A (en)	1987-12-31
FI66609B (fi)	1984-07-31
PL125789B1 (en)	1983-06-30
HU184222B (en)	1984-07-30
JPS55105679A (en)	1980-08-13
AU5438180A (en)	1980-07-17
ES8101586A1 (es)	1980-12-16
US4335127A (en)	1982-06-15
DK7280A (da)	1980-07-09
ZA8082B (en)	1981-08-26
RO79148A (ro)	1982-08-17
KR830001926A (ko)	1983-05-19
SG48684G (en)	1985-03-29
FI66609C (fi)	1984-11-12
KR850000684B1 (ko)	1985-05-14
IE49351B1 (en)	1985-09-18
IE800021L (en)	1980-07-08
GR67304B (da)	1981-06-29
DK170669B1 (da)	1995-11-27
KR850000683B1 (ko)	1985-05-14
JPS6346753B2 (da)	1988-09-19
EP0013612A3 (en)	1980-10-15
YU42957B (en)	1989-02-28
EP0013612B1 (en)	1983-11-09
SU1041034A3 (ru)	1983-09-07
KR850000677B1 (ko)	1985-05-10
MA18694A1 (fr)	1980-10-01
EP0013612A2 (en)	1980-07-23
ATE5258T1 (de)	1983-11-15
PL221249A1 (da)	1980-12-01

Legal Events

Date	Code	Title	Description
1997-06-02	AT	Record of annual fee payments	Year of fee payment: 13

Publication	Publication Date	Title
ZA8082B (en)	1981-08-26	Novel (piperidinylalkyl) quinazoline derivatives
NZ330656A (en)	1999-06-29	Tricyclic compounds, their production and use
ES8504718A1 (es)	1985-05-01	Un metodo para preparar derivados de 4-hidroxi-2-quinolona.
IE802684L (en)	1981-06-21	Quinoline derivatives
ES8103746A1 (es)	1981-03-16	Procedimiento para la preparacion de 4-aril-5,6,7,8-tetrahi-dropirazolo (3,4b) (1,5) diazepin-1h,4h-5,7-dionas
AU4934685A (en)	1986-05-15	3-Amino-2,3-dihydro-1-benzoxepine-compounds and methods for their preparation and pharmaceutical preparations containing these compounds
DE3361834D1 (en)	1986-02-27	Dithiino (1,4) (2,3-c) pyrrole derivatives, their preparation and pharmaceutical compositions containing them
DE3775905D1 (de)	1992-02-20	Purin-histamin-h1-antagonisten, ihre herstellung und sie enthaltende pharmazeutische praeparate.